These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10969040)

  • 1. Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes.
    Yuan SY; Ustinova EE; Wu MH; Tinsley JH; Xu W; Korompai FL; Taulman AC
    Circ Res; 2000 Sep; 87(5):412-7. PubMed ID: 10969040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability.
    Huang Q; Yuan Y
    Am J Physiol; 1997 Nov; 273(5):H2442-51. PubMed ID: 9374783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage.
    Yuan SY; Wu MH; Ustinova EE; Guo M; Tinsley JH; De Lanerolle P; Xu W
    Circ Res; 2002 Jun; 90(11):1214-21. PubMed ID: 12065325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of paxillin/pp125FAK and microvascular endothelial barrier function.
    Yuan Y; Meng FY; Huang Q; Hawker J; Wu HM
    Am J Physiol; 1998 Jul; 275(1):H84-93. PubMed ID: 9688899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability.
    Wu HM; Yuan Y; Zawieja DC; Tinsley J; Granger HJ
    Am J Physiol; 1999 Feb; 276(2):H535-42. PubMed ID: 9950855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats.
    Wei L; Yin Z; Yuan Y; Hwang A; Lee A; Sun D; Li F; Di C; Zhang R; Cao F; Wang H
    Microvasc Res; 2010 Jul; 80(1):158-65. PubMed ID: 20079359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability.
    Gaudreault N; Perrin RM; Guo M; Clanton CP; Wu MH; Yuan SY
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1527-33. PubMed ID: 18497307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha.
    Ferro T; Neumann P; Gertzberg N; Clements R; Johnson A
    Am J Physiol Lung Cell Mol Physiol; 2000 Jun; 278(6):L1107-17. PubMed ID: 10835315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of protein kinase C activation and the vascular complications of diabetes.
    Das Evcimen N; King GL
    Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain.
    Scalia R; Gong Y; Berzins B; Zhao LJ; Sharma K
    Diabetes; 2007 Jul; 56(7):1842-9. PubMed ID: 17446533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor.
    Wu MH; Guo M; Yuan SY; Granger HJ
    J Physiol; 2003 Nov; 552(Pt 3):691-9. PubMed ID: 12949227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
    Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of high glucose and phorbol-myristate-acetate-induced endothelial cell permeability by protein kinase C inhibitors LY379196 and hypocrellin A.
    Dang L; Seale JP; Qu X
    Biochem Pharmacol; 2004 Mar; 67(5):855-64. PubMed ID: 15104238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability.
    Sun H; Breslin JW; Zhu J; Yuan SY; Wu MH
    Microcirculation; 2006; 13(3):237-47. PubMed ID: 16627366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats.
    Mooradian AD; Haas MJ; Batejko O; Hovsepyan M; Feman SS
    Diabetes; 2005 Oct; 54(10):2977-82. PubMed ID: 16186401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein transfection of intact microvessels specifically modulates vasoreactivity and permeability.
    Tinsley JH; Zawieja DC; Wu MH; Ustinova EE; Xu W; Yuan SY
    J Vasc Res; 2001; 38(5):444-52. PubMed ID: 11561146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules.
    Wu MH; Yuan SY; Granger HJ
    J Physiol; 2005 Feb; 563(Pt 1):95-104. PubMed ID: 15539400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element.
    Birch KA; Heath WF; Hermeling RN; Johnston CM; Stramm L; Dell C; Smith C; Williamson JR; Reifel-Miller A
    Diabetes; 1996 May; 45(5):642-50. PubMed ID: 8621017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C activity contributes to endothelial hyperpermeability during early angiogenesis in the chick chorioallantoic membrane.
    Defouw LM; Defouw DO
    Tissue Cell; 2001 Apr; 33(2):135-40. PubMed ID: 11392665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal adhesion kinase in neutrophil-induced microvascular hyperpermeability.
    Guo M; Wu MH; Granger HJ; Yuan SY
    Microcirculation; 2005 Mar; 12(2):223-32. PubMed ID: 15824042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.